Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Wilhelmi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical and Molecular Hepatology|March 23, 2021
Clinical and serological prognostic markers in primary biliary cholangitisMarkus Wilhelmi
The Journal of Pediatrics|February 2, 2022
Autoantibodies in children with overweight and obesity with nonalcoholic fatty liver disease: the major role of laboratory techniqueMarkus Wilhelmi
Journal of Clinical and Experimental Hepatology|December 6, 2021
Isolated Hepatic Tuberculosis: A Difficult DiagnosisMarkus Wilhelmi
The Journal of Applied Laboratory Medicine|March 24, 2022
The Pivotal Role of Liver Autoimmune Serology in the Diagnosis of Autoimmune Liver DiseaseMarkus Wilhelmi
Asia-Pacific Journal of Clinical Oncology|July 5, 2021
Adverse events of immune checkpoint inhibitors in advanced hepatocellular carcinoma and their prognostic significanceMarkus Wilhelmi
Gastroenterology and Hepatology From Bed to Bench|May 10, 2021
Letter to: neurological manifestation of coeliac disease: many immunological markers suggesting a further expression of gluten-induced secondary autoimmunityMarkus Wilhelmi
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 28, 2021
Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabineMarkus Wilhelmi
Clinical Biochemistry|April 23, 2021
Diagnostic significance of uncommon antinuclear antibodiesMarkus Wilhelmi
Chinese Clinical Oncology|April 25, 2021
Ramucirumab and other new systemic therapies for hepatocellular carcinoma: still uncovered the problem of Child-Pugh B patientsMarkus Wilhelmi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 26, 2022
Age Dependence of Liver Enzymes: Celiac Disease Should Also Be ConsideredMarkus Wilhelmi, Daniel Meier
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical and Molecular Hepatology|March 23, 2021
Clinical and serological prognostic markers in primary biliary cholangitisMarkus Wilhelmi
The Journal of Pediatrics|February 2, 2022
Autoantibodies in children with overweight and obesity with nonalcoholic fatty liver disease: the major role of laboratory techniqueMarkus Wilhelmi
Journal of Clinical and Experimental Hepatology|December 6, 2021
Isolated Hepatic Tuberculosis: A Difficult DiagnosisMarkus Wilhelmi
The Journal of Applied Laboratory Medicine|March 24, 2022
The Pivotal Role of Liver Autoimmune Serology in the Diagnosis of Autoimmune Liver DiseaseMarkus Wilhelmi
Asia-Pacific Journal of Clinical Oncology|July 5, 2021
Adverse events of immune checkpoint inhibitors in advanced hepatocellular carcinoma and their prognostic significanceMarkus Wilhelmi
Gastroenterology and Hepatology From Bed to Bench|May 10, 2021
Letter to: neurological manifestation of coeliac disease: many immunological markers suggesting a further expression of gluten-induced secondary autoimmunityMarkus Wilhelmi
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 28, 2021
Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabineMarkus Wilhelmi
Clinical Biochemistry|April 23, 2021
Diagnostic significance of uncommon antinuclear antibodiesMarkus Wilhelmi
Chinese Clinical Oncology|April 25, 2021
Ramucirumab and other new systemic therapies for hepatocellular carcinoma: still uncovered the problem of Child-Pugh B patientsMarkus Wilhelmi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 26, 2022
Age Dependence of Liver Enzymes: Celiac Disease Should Also Be ConsideredMarkus Wilhelmi, Daniel Meier
Pageof 1